Literature DB >> 10099180

Proposed mechanism of acetate accumulation in two recombinant Escherichia coli strains during high density fermentation.

M van de Walle1, J Shiloach.   

Abstract

The productivity of Escherichia coli as a producer of recombinant proteins is affected by its metabolic properties, especially by acetate production. Two commercially used E. coli strains, BL21 (lambdaDE3) and JM109, differ significantly in their acetate production during batch fermentation at high initial glucose concentrations. E. coli BL21 grows to an optical density (OD, 600 nm) of 100 and produces no more than 2 g/L acetate, while E. coli JM109 grows to an OD (600 nm) of 80 and produces up to 14 g/L acetate. Even in fed-batch fermentation, when glucose concentration is maintained between 0.5 and 1.0 g/L, JM109 accumulates 4 times more acetate than BL21. To investigate the difference between the two strains, metabolites and enzymes involved in carbon utilization and acetate production were analyzed (isocitrate, ATP, phosphoenolpyruvate, pyruvate, isocitrate lyase, and isocitrate dehydrogenase). The results showed that during batch fermentation isocitrate lyase activity and isocitrate concentration were higher in BL21 than in JM109, while pyruvate concentration was higher in JM109. The activation of the glyoxylate shunt pathway at high glucose concentrations is suggested as a possible explanation for the lower acetate accumulation in E. coli BL21. Metabolic flux analysis of the batch cultures supports the activity of the glyoxylate shunt in E. coli BL21. Copyright 1998 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10099180     DOI: 10.1002/(sici)1097-0290(19980105)57:1<71::aid-bit9>3.0.co;2-s

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  16 in total

Review 1.  The acetate switch.

Authors:  Alan J Wolfe
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

2.  Effects of growth mode and pyruvate carboxylase on succinic acid production by metabolically engineered strains of Escherichia coli.

Authors:  G N Vemuri; M A Eiteman; E Altman
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

3.  Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21.

Authors:  Alexander Rodríguez; Angela J Espejo; Alejandra Hernández; Olga L Velásquez; Lina M Lizaraso; Henry A Cordoba; Oscar F Sánchez; Carlos J Alméciga-Díaz; Luis A Barrera
Journal:  J Ind Microbiol Biotechnol       Date:  2010-06-27       Impact factor: 3.346

4.  Metabolic analysis of Escherichia coli in the presence and absence of the carboxylating enzymes phosphoenolpyruvate carboxylase and pyruvate carboxylase.

Authors:  R R Gokarn; M A Eiteman; E Altman
Journal:  Appl Environ Microbiol       Date:  2000-05       Impact factor: 4.792

5.  Characterization of growth and acid formation in a Bacillus subtilis pyruvate kinase mutant.

Authors:  B Fry; T Zhu; M M Domach; R R Koepsel; C Phalakornkule; M M Ataai
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

6.  Evaluating microarrays using a semiparametric approach: application to the central carbon metabolism of Escherichia coli BL21 and JM109.

Authors:  Je-Nie Phue; Benjamin Kedem; Pratik Jaluria; Joseph Shiloach
Journal:  Genomics       Date:  2006-11-27       Impact factor: 5.736

Review 7.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

8.  Glucose uptake regulation in E. coli by the small RNA SgrS: comparative analysis of E. coli K-12 (JM109 and MG1655) and E. coli B (BL21).

Authors:  Alejandro Negrete; Weng-Ian Ng; Joseph Shiloach
Journal:  Microb Cell Fact       Date:  2010-09-28       Impact factor: 5.328

Review 9.  Minimizing acetate formation in E. coli fermentations.

Authors:  Marjan De Mey; Sofie De Maeseneire; Wim Soetaert; Erick Vandamme
Journal:  J Ind Microbiol Biotechnol       Date:  2007-08-01       Impact factor: 3.346

10.  Metabolic engineering of Escherichia coli for enhanced production of (R)- and (S)-3-hydroxybutyrate.

Authors:  Hsien-Chung Tseng; Collin H Martin; David R Nielsen; Kristala L Jones Prather
Journal:  Appl Environ Microbiol       Date:  2009-03-20       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.